Amneal Pharmaceuticals, Inc. (AMRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 722.52M | 814.32M | 784.51M | 724.51M | 695.42M | 730.52M | 702.47M | 701.78M | 659.19M | 616.98M | 620.04M | 599.05M |
| Revenue Growth % | 3.9% | 11.47% | 11.68% | 3.24% | 5.5% | 18.4% | 13.29% | 17.15% | 18.23% | 1.18% | 13.65% | 7.1% |
| Cost of Goods Sold | 402.41M | 517.13M | 510.54M | 438.25M | 439.53M | 467.64M | 432.91M | 451.83M | 421.13M | 391.5M | 387.51M | 379.02M |
| COGS % of Revenue | 55.69% | 63.5% | 65.08% | 60.49% | 63.2% | 64.02% | 61.63% | 64.38% | 63.89% | 63.45% | 62.5% | 63.27% |
| Gross Profit | 320.11M | 297.19M | 273.97M | 286.25M | 255.89M | 262.87M | 269.56M | 249.95M | 238.06M | 225.48M | 232.53M | 220.02M |
| Gross Margin % | 44.31% | 36.5% | 34.92% | 39.51% | 36.8% | 35.98% | 38.37% | 35.62% | 36.11% | 36.55% | 37.5% | 36.73% |
| Gross Profit Growth % | 25.1% | 13.05% | 1.64% | 14.53% | 7.49% | 16.58% | 15.92% | 13.6% | 33.6% | 4.69% | 19.72% | 9.73% |
| Operating Expenses | 186.58M | 182.69M | 274.09M | 174.88M | 155.54M | 187.08M | 180.75M | 154.48M | 248.81M | 211.29M | 156.88M | 139.94M |
| OpEx % of Revenue | 25.82% | 22.43% | 34.94% | 24.14% | 22.37% | 25.61% | 25.73% | 22.01% | 37.74% | 34.25% | 25.3% | 23.36% |
| Selling, General & Admin | 186.58M | 146.46M | 137.81M | 124.27M | 118.29M | 128.69M | 118.69M | 116.46M | 112.59M | 109M | 113.01M | 105.57M |
| SG&A % of Revenue | 25.82% | 17.99% | 17.57% | 17.15% | 17.01% | 17.62% | 16.9% | 16.6% | 17.08% | 17.67% | 18.23% | 17.62% |
| Research & Development | 38.38M | 34.82M | 63.35M | 49.98M | 41.81M | 56.12M | 61.1M | 37.1M | 39.3M | 46.56M | 42.26M | 38.62M |
| R&D % of Revenue | 5.31% | 4.28% | 8.08% | 6.9% | 6.01% | 7.68% | 8.7% | 5.29% | 5.96% | 7.55% | 6.82% | 6.45% |
| Other Operating Expenses | -1000K | 1000K | 1000K | 634K | -1000K | 1000K | 960K | 919K | 1000K | 1000K | 1000K | -1000K |
| Operating Income | 133.54M | 114.5M | -117K | 111.37M | 100.35M | 75.79M | 88.81M | 95.47M | -10.75M | 14.19M | 75.65M | 80.08M |
| Operating Margin % | 18.48% | 14.06% | -0.01% | 15.37% | 14.43% | 10.38% | 12.64% | 13.6% | -1.63% | 2.3% | 12.2% | 13.37% |
| Operating Income Growth % | 33.08% | 51.07% | -100.13% | 16.66% | 1033.81% | 434.02% | 17.4% | 19.21% | -131.19% | -60.61% | 70.56% | 140.32% |
| EBITDA | 176.73M | 163.73M | 53.96M | 171.49M | 160.51M | 141.92M | 147.77M | 151.04M | 44.78M | 71.13M | 132.85M | 137.19M |
| EBITDA Margin % | 24.46% | 20.11% | 6.88% | 23.67% | 23.08% | 19.43% | 21.04% | 21.52% | 6.79% | 11.53% | 21.43% | 22.9% |
| EBITDA Growth % | 10.11% | 15.36% | -63.49% | 13.53% | 258.42% | 99.54% | 11.23% | 10.09% | -51.64% | -26.74% | 25.38% | 198.76% |
| D&A (Non-Cash Add-back) | 43.19M | 49.23M | 54.07M | 60.11M | 60.16M | 66.13M | 58.96M | 55.57M | 55.53M | 56.93M | 57.21M | 57.11M |
| EBIT | 133.54M | 111.47M | 57.59M | 116.81M | 94.42M | 46.34M | 80.93M | 86.12M | -9.82M | -23.91M | 73.87M | 80.52M |
| Net Interest Income | -53.36M | -56.24M | -62.81M | -65.1M | -56.94M | -61.66M | -65.51M | -65.72M | -65.7M | -59.55M | -50.91M | -50.86M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 53.36M | 56.24M | 62.81M | 65.1M | 56.94M | 61.66M | 65.51M | 65.72M | 65.7M | 59.55M | 50.91M | 50.86M |
| Other Income/Expense | -53.36M | -59.27M | -5.11M | -59.66M | -62.86M | -91.11M | -73.39M | -75.06M | -64.78M | -97.65M | -52.69M | -50.42M |
| Pretax Income | 80.18M | 55.23M | -5.22M | 51.71M | 37.49M | -15.32M | 15.42M | 20.41M | -75.52M | -83.46M | 22.96M | 29.66M |
| Pretax Margin % | 11.1% | 6.78% | -0.67% | 7.14% | 5.39% | -2.1% | 2.2% | 2.91% | -11.46% | -13.53% | 3.7% | 4.95% |
| Income Tax | 2.18M | 5.66M | -23.36M | 16.1M | 12.87M | 5.42M | 3.67M | 3.62M | 6.16M | 9.88M | -2.08M | -23K |
| Effective Tax Rate % | 2.71% | 10.25% | 447.16% | 31.14% | 34.33% | -35.4% | 23.77% | 17.73% | -8.15% | -11.84% | -9.04% | -0.08% |
| Net Income | 62.5M | 35.08M | 2.37M | 22.42M | 12.2M | -31.08M | -156K | 5.99M | -91.64M | -98.65M | 9.68M | 11.92M |
| Net Margin % | 8.65% | 4.31% | 0.3% | 3.09% | 1.75% | -4.25% | -0.02% | 0.85% | -13.9% | -15.99% | 1.56% | 1.99% |
| Net Income Growth % | 412.48% | 212.85% | 1618.59% | 273.99% | 113.31% | 68.49% | -101.61% | -49.7% | -1219.93% | -2176.69% | 460.06% | 109.86% |
| Net Income (Continuing) | 78M | 49.57M | 18.13M | 35.61M | 24.62M | -20.74M | 11.76M | 16.79M | -81.68M | -93.34M | 25.03M | 29.68M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -558K | 76.76M | -497K | 65.8M | 72.28M | 64.73M | 59.75M | 53.4M | 47.12M | 41.52M | -139.48M | -135.29M |
| EPS (Diluted) | 0.19 | 0.11 | 0.01 | 0.07 | 0.04 | -0.10 | -0.00 | 0.02 | -0.30 | -0.40 | 0.06 | 0.08 |
| EPS Growth % | 405.32% | 210% | - | 269.68% | 112.53% | 75% | -100.83% | -76.5% | -351.81% | -933.59% | 479.75% | 110% |
| EPS (Basic) | 0.19 | 0.11 | 0.01 | 0.07 | 0.04 | -0.10 | -0.00 | 0.02 | -0.30 | -0.40 | 0.06 | 0.08 |
| Diluted Shares Outstanding | 328.93M | 324.81M | 324.75M | 322.36M | 323.96M | 309.85M | 309.65M | 318.96M | 307.28M | 243.71M | 159.69M | 154.89M |
| Basic Shares Outstanding | 328.93M | 313.37M | 314.17M | 313.74M | 311.05M | 309.85M | 309.65M | 309.12M | 305.48M | 243.71M | 161.37M | 153.74M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |